PDS Biotechnology Corporation (PDSB): Price and Financial Metrics
PDSB Price/Volume Stats
| Current price | $1.65 | 52-week high | $6.68 |
| Prev. close | $1.75 | 52-week low | $1.53 |
| Day low | $1.63 | Volume | 579,000 |
| Day high | $1.81 | Avg. volume | 595,913 |
| 50-day MA | $2.60 | Dividend yield | N/A |
| 200-day MA | $3.22 | Market Cap | 61.72M |
PDSB Stock Price Chart Interactive Chart >
PDS Biotechnology Corporation (PDSB) Company Bio
PDS Biotechnology Corporation, a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products, today announced the closing of its merger with Edge Therapeutics, Inc. Following the merger, Edge will operate as “PDS Biotechnology Corporation” and the stock will trade on the Nasdaq Capital Market beginning on March 18, 2019 under the ticker symbol \
PDSB Price Returns
| 1-mo | -25.00% |
| 3-mo | -48.44% |
| 6-mo | -42.31% |
| 1-year | -69.04% |
| 3-year | -81.25% |
| 5-year | -25.34% |
| YTD | -66.80% |
| 2023 | -62.35% |
| 2022 | 62.96% |
| 2021 | 278.50% |
| 2020 | -19.25% |
| 2019 | -58.72% |
Loading social stream, please wait...